RESUMEN
Dosimetric characteristics of brachytherapy sources are normally determined in water using a Monte Carlo simulation technique and in water equivalent phantom material using both experimental and Monte Carlo simulation techniques. The consensuses of these results are then calculated for clinical applications by converting experimental data obtained in water equivalent material to water using a conversion factor. These conversion factors are normally determined as a ratio of the Monte Carlo-simulated dose rate constant in liquid water to the dose rate constant in a water-equivalent phantom material. However, it has been noted that conversion factors utilized by some investigators have been derived using incorrect phantom material composition and incorrect cross-sectional data information. The impact of errors associated with the cross-sectional data and chemical composition of the phantom material used in dosimetric evaluation of brachytherapy sources has been investigated in this project. Results of these investigations have shown that the use of Solid Water with 1.7% calcium content, as compared to the 2.3% value stated by the manufacturer, may lead to 5% and 9% differences in conversion factors for 125I and 103Pd, respectively.
Asunto(s)
Braquiterapia/normas , Radioisótopos de Yodo/normas , Paladio/normas , Radiometría/normas , Agua/química , Agua/normas , Radioisótopos de Yodo/química , Isótopos/química , Isótopos/normas , Paladio/química , Radiofármacos/química , Radiofármacos/normas , Dosificación Radioterapéutica , Estándares de Referencia , Valores de Referencia , Estados UnidosRESUMEN
ADVANTAGE Pd-103 brachytherapy source has been recently introduced by IsoAid for prostate permanent implants. Dosimetric characteristics (Dose rate constant, radial dose function, 2D-, and 1D-anisotropy functions) of this source model have been determined using both theoretical and experimental methods, following the updated TG-43U1 protocol. Derivation of the dose rate constant was based on recent NIST WAFAC calibration performed in accordance with the 1999 Standards. Measurements were performed in Solid Water using LiF TLD chips and the theoretical calculations were performed in Solid Water and liquid water phantom materials using PTRAN Monte Carlo code. The results of the Monte Carlo simulation have shown a dose rate constant of 0.69 cGyh(-1) U(-1) in liquid water and 0.67 cGyh(-1) U(-1) in Solid Water medium. The measured dose rate constant in Solid Water was found to be 0.68+/-8% cGyh(-1) U(-1), which is in a good agreement (within +/-5%) to the Monte Carlo simulated data. The 2D- and 1D-anisotropy functions of the ADVANTAGE Pd-103 source were calculated for radial distances ranging from 0.5 to 5.0 cm. Radial dose function was determined for radial distances ranging from 0.2 to 8.0 cm using line source approximation. All these calculations are based on L(eff) equal to 3.61 cm, calculated following TG-43U1 recommendations. The tabulated data for 2D-anisotropy function, 1D-anisotropy function, dose rate constant and radial dose function have been produced for clinical application of this source model.
Asunto(s)
Braquiterapia/instrumentación , Modelos Biológicos , Paladio/análisis , Paladio/uso terapéutico , Radiometría/métodos , Planificación de la Radioterapia Asistida por Computador/métodos , Carga Corporal (Radioterapia) , Braquiterapia/métodos , Braquiterapia/normas , Calibración , Simulación por Computador , Diseño de Equipo , Análisis de Falla de Equipo , Humanos , Paladio/normas , Radioisótopos/análisis , Radioisótopos/normas , Radioisótopos/uso terapéutico , Radiometría/normas , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por Computador/normas , Efectividad Biológica Relativa , Estados UnidosRESUMEN
In March 2004, the recommendations of the American Association of Physicists in Medicine (AAPM) on the interstitial brachytherapy dosimetry using 125I and 103Pd were reported in Medical Physics [TG-43 Update: Rivard et al., 31, 633-674 (2004)]. These recommendations include some minor changes in the dose-calculation formalism and a major update of the dosimetry parameters for eight widely used interstitial brachytherapy sources. A full implementation of these recommendations could result in unintended changes in delivered dose without corresponding revisions in the prescribed dose. Because most published clinical experience with permanent brachytherapy is based upon two widely used source models, the 125I Model 6711 and 103Pd Model 200 sources, in this report we present an analysis of the dosimetric impact of the 2004 TG-43 dosimetry parameters on the history of dose delivery for these two source models. Our analysis indicates that the currently recommended prescribed dose of 125 Gy for Model 200 103Pd implants planned using previously recommended dosimetry parameters [AAPM 103Pd dose prescription: Williamson et al., Med. Phys. 27, 634-642 (2000)] results in a delivered dose of 120 Gy according to dose calculations based on the 2004 TG-43 update. Further, delivered doses prior to October 1997 varied from 113 to 119 Gy for a prescribed dose of 115 Gy compared to 124 Gy estimated by the AAPM 2000 report. For 125I implants using Model 6711 seeds, there are no significant changes (less than 2%). Practicing physicians should take these results into account when selecting the clinically appropriate prescribed dose for 103Pd interstitial implant patients following implementation of the 2004 TG-43 update dose-calculation recommendations. The AAPM recommends that the radiation oncology community review this report and consider whether the currently recommended dose level (125 Gy) needs to be revised.
Asunto(s)
Braquiterapia/métodos , Braquiterapia/normas , Radioisótopos de Yodo/uso terapéutico , Paladio/uso terapéutico , Guías de Práctica Clínica como Asunto , Radiometría/métodos , Radiometría/normas , Anisotropía , Calibración , Adhesión a Directriz , Humanos , Radioisótopos de Yodo/normas , Modelos Estadísticos , Método de Montecarlo , Paladio/normas , Fotones , Radiofármacos/uso terapéutico , Dosificación RadioterapéuticaRESUMEN
PURPOSE: Three types of radiation sources are employed currently in the radiation treatment of prostate cancer, namely, external, implant, and high-dose-rate (HDR) sources using an afterloader method. The present article provides a detailed dosimetric characterization of several commercially available implant sources and an HDR source employing the same stochastic code and dataset. METHODS AND MATERIALS: The radioactive implants considered are (125)I seeds: models 6701, 6702 and 6711, (103)Pd seed: model 200, and a high-dose-rate (192)Ir source: microSelectron-HDR model V7.0x. Detailed modeling of the sources and their associated X-rays and gamma rays has been carried out using the stochastic code MCNP4C. A sensitivity study has been conducted to quantify effects of varying the composition and density of the tissue equivalent material, and a dosimetric comparison is made for different media (tissue equivalent, solid-water, water, and air). Furthermore, a set of measurements using thermoluminescent dosimeters has been done to provide experimental validation of some of the calculational results obtained. RESULTS: Effectively, high-precision dosimetric values (Monte-Carlo statistical 1-sigma error <1%) are provided in tabulated form over a wide range to enable therapy planning as well as to check numerical values calculated by other methods. A subset of calculated dosimetric values has been experimentally validated by using thermoluminescent dosimeters. CONCLUSIONS: A detailed comparison of results obtained for the radial dose distribution function, anisotropy factor, and dose rate constant as defined in the TG-43 protocol has indicated reasonable agreement with the values reported in the literature.
Asunto(s)
Braquiterapia/instrumentación , Neoplasias de la Próstata/radioterapia , Radioisótopos/normas , Simulación por Computador , Humanos , Radioisótopos de Yodo/normas , Radioisótopos de Yodo/uso terapéutico , Radioisótopos de Iridio/normas , Radioisótopos de Iridio/uso terapéutico , Masculino , Paladio/normas , Paladio/uso terapéutico , Radioisótopos/uso terapéutico , Radiometría , Radioterapia Asistida por ComputadorRESUMEN
A new brachytherapy source having 103Pd adsorbed onto silver beads has been designed. The dose distributions of this source have been characterized using version 5 of the MCNP Monte Carlo radiation transport code available from Oak Ridge National Laboratory. These results are presented in terms of the updated AAPM Task Group No. 43 (TG-43U1) formalism, dosimetry parameters, and recommended calculation methodology.
Asunto(s)
Braquiterapia/métodos , Braquiterapia/normas , Método de Montecarlo , Paladio/análisis , Paladio/uso terapéutico , Radiometría/métodos , Radiometría/normas , Planificación de la Radioterapia Asistida por Computador/métodos , Planificación de la Radioterapia Asistida por Computador/normas , Carga Corporal (Radioterapia) , Braquiterapia/instrumentación , Simulación por Computador , Análisis de Falla de Equipo/métodos , Análisis de Falla de Equipo/normas , Humanos , Modelos Biológicos , Paladio/normas , Guías de Práctica Clínica como Asunto , Radioisótopos/análisis , Radioisótopos/normas , Radioisótopos/uso terapéutico , Radiofármacos/análisis , Radiofármacos/normas , Radiofármacos/uso terapéutico , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por Computador/instrumentación , Estándares de Referencia , Efectividad Biológica Relativa , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Estados UnidosRESUMEN
Palladium 103 is a radionuclide used in brachytherapy sources for the treatment of prostate cancers and also for other medical applications. It decays through electron capture to excited levels of 103Rh. This paper describes the calculation method used to compute the detection efficiency in the framework of the triple to double coincidence ratio model. The calculation of the energy transferred to the scintillator is made by considering the various atomic events following the electron capture and the electron conversion. The energy deposited in the scintillator after the absorption of X-rays is calculated using the PENELOPE stochastic calculation code. The main contributors to the final uncertainty and their covariance matrix are discussed. As the calculation method cannot be reduced to an explicit function, this paper describes the Monte Carlo method used for the evaluation of uncertainties.
Asunto(s)
Braquiterapia/normas , Calibración/normas , Paladio/análisis , Paladio/normas , Radioisótopos/análisis , Radioisótopos/normas , Conteo por Cintilación/métodos , Conteo por Cintilación/normas , Algoritmos , Partículas beta , Diseño de Equipo , Análisis de Falla de Equipo , Francia , Radiofármacos/análisis , Radiofármacos/normas , Estándares de Referencia , Reproducibilidad de los Resultados , Conteo por Cintilación/instrumentación , Sensibilidad y Especificidad , Soluciones , Espectrometría gamma/instrumentación , Espectrometría gamma/métodos , Espectrometría gamma/normasAsunto(s)
Braquiterapia/métodos , Paladio/uso terapéutico , Radioisótopos/uso terapéutico , Fenómenos Biofísicos , Biofisica , Braquiterapia/normas , Humanos , Masculino , Paladio/administración & dosificación , Paladio/normas , Neoplasias de la Próstata/radioterapia , Radioisótopos/administración & dosificación , Radioisótopos/normas , Dosificación Radioterapéutica , Estándares de ReferenciaRESUMEN
Three new titanium alloys with Zr, Nb, Ta, Pd and In as alloying elements were developed and compared with currently used implant metals, namely, pure Ti and Ti-6Al-4V alloy, in terms of mechanical and corrosion properties, and cytotoxicity. New alloys showed comparable mechanical properties with that of the Ti-6Al-4V alloy, but increased corrosion potential, somewhat decreased breakdown potential and increased corrosion rate. There were no significant differences in cell growth on the surface of the various metal specimens, indicating that the cells cannot differentiate between the passivated surfaces of the various Ti metals.
Asunto(s)
Aleaciones/normas , Implantes Dentales/normas , Indio/normas , Niobio/normas , Paladio/normas , Tantalio/normas , Titanio/normas , Circonio/normas , Fenómenos Biomecánicos , Corrosión , Implantación Dental Endoósea , Pruebas de Dureza , Humanos , Ensayo de Materiales , Diseño de Prótesis , Pruebas de ToxicidadAsunto(s)
Braquiterapia/normas , Radioisótopos de Yodo/normas , Paladio/normas , Radioisótopos/normas , Braquiterapia/instrumentación , Humanos , Radioisótopos de Yodo/uso terapéutico , Masculino , Paladio/uso terapéutico , Neoplasias de la Próstata/radioterapia , Garantía de la Calidad de Atención de Salud , Radioisótopos/uso terapéuticoRESUMEN
A wet oxidation is considered to be one of the most effective methods of waste processing and recycling in CELSS (Controlled Ecological Life Support System). The first test using rabbit waste as raw material was conducted under a decomposition temperature of 280 degrees C for 30 minutes and an initial pure oxygen pressure of 4.9 MPa (50 kgf/cm2) before heating, and the following results were obtained. The value of COD (Chemical Oxygen Demand) was reduced 82.5% by the wet oxidation. And also the Kjeldahl nitrogen concentration was decreased 98.8%. However, the organic carbon compound in the residual solution was almost acetic acid and ammonia was produced. In order to activate the oxidation more strongly, the second tests using catalysts such as Pd, Ru and Ru+Rh were conducted. As the results of these tests, the effectiveness of catalysts for oxidizing raw material was shown as follows: COD and the Kjeldahl nitrogen values were drastically decreased 99.65% and 99.88%, respectively. Furthermore, the quantity of acetic acid and ammonia were reduced considerably. On the other hand, nitrate was showed a value 30 times as much as without catalytic oxidation.